Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Koukoulitsa, C.; Bailly, F.; Pegklidou, K.; Demopoulos, V.J.; Cotelle, P.
    Evaluation of aldose reductase inhibition and docking studies of 6-nitro and 6,6-dinitrorosmarinic acids (2010), Eur. J. Med. Chem., 45, 1663-1666.
    View publication on PubMed

Application

EC Number Application Comment Organism
1.1.1.21 medicine aldose reductase ALR2 is a target enzyme for the treatment of diabetic complications Homo sapiens

Inhibitors

EC Number Inhibitors Comment Organism Structure
1.1.1.21 6',6''-dinitrorosmarinic acid docking structure with ALR2, overview Homo sapiens
1.1.1.21 6'-nitrorosmarinic acid docking structure with ALR2, overview Homo sapiens
1.1.1.21 rosmarinic acid docking structure with ALR2, overview Homo sapiens

Organism

EC Number Organism UniProt Comment Textmining
1.1.1.21 Homo sapiens P15121 ALR2
-

Synonyms

EC Number Synonyms Comment Organism
1.1.1.21 aldose reductase
-
Homo sapiens
1.1.1.21 ALR2
-
Homo sapiens

General Information

EC Number General Information Comment Organism
1.1.1.21 metabolism aldose reductase ALR2 acts in the polyol metabolic pathway Homo sapiens